{"id":"W3188150096","doi":"10.60692/hb41n-f3v45","title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz‐Containing Antiretroviral Therapy","year":2019,"lang":"en","type":"article","venue":"PMC","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Efavirenz; CYP2B6; Reverse-transcriptase inhibitor; Discontinuation; Medicine; Pharmacogenetics; Guideline; Pharmacology; Adverse effect; Internal medicine; Antiretroviral therapy; Virology; Genotype; Human immunodeficiency virus (HIV); Biology; Cytochrome P450; CYP1A2; Genetics; Viral load; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01497026,0.0009969415,0.001546399,0.002278526,0.001017366,0.002805209,0.004001219,0.00875752,0.01129101],"category_scores_gemma":[0.0367649,0.0007612456,0.003086842,0.002520946,0.00112196,0.001633839,0.001823778,0.01119278,0.008828388],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002475311,"about_ca_system_score_gemma":0.01737357,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0170025,"about_ca_topic_score_gemma":0.02252929,"domain_scores_codex":[0.9794764,0.009110392,0.004079437,0.0006223989,0.005755445,0.000955866],"domain_scores_gemma":[0.9675847,0.01039933,0.003319902,0.001060562,0.01580217,0.001833352],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000134602,0.0002519402,0.0009188172,0.001459619,0.0000696209,0.0005108014,0.0001825844,0.0006583235,0.0007326581,0.009033614,0.8100249,0.1760226],"study_design_scores_gemma":[0.0002766699,0.0001281561,0.003547546,0.006394435,0.0001382203,0.0009463309,0.000107466,0.0007181768,0.000648025,0.006041539,0.981003,0.00005043282],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"methods","genre_scores_codex":[0.004067129,0.0984313,0.07625489,0.453619,0.01966053,0.00747443,0.01640565,0.00355887,0.3205282],"genre_scores_gemma":[0.04031295,0.1284215,0.2912182,0.3475581,0.01137351,0.01740478,0.03920656,0.00157329,0.1229311],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.0170025,"threshold_uncertainty_score":0.07917124,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05029756246244185,"score_gpt":0.4199689223152229,"score_spread":0.3696713598527811,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}